Le Lézard
Classified in: Health, Science and technology
Subject: LAW

Nexia Health Provides Update on Arbitration Matter


/NOT FOR DISTRIBUTION IN THE UNITED STATES OR THROUGH UNITED STATES WIRE SERVICES/

MARKHAM, ON, Aug. 13, 2018 /CNW/ - Nexia Health Technologies Inc. (TSXV: NGH.H) (the "Company") is providing an update of the status of its previously disclosed legal dispute with a software vendor (the "Claimant"). 

The Company previously disclosed that, on January 26, 2018, the arbitrator issued a final partial award in the Claimant's favour whereby it upheld certain claims for breach of contract and indicated it would determine the quantum of damages following further submissions by the parties. These additional submissions took place in April and May 2018 and on August 10, 2018, the Company was advised that the arbitrator had awarded damages in favour of the Claimant of approximately $2,000,000, including approximately $410,000 in respect of the Claimant's claim for interest due and approximately $140,000 for the Claimant's share of arbitration costs.

The Company and its legal counsel strongly disagree with the arbitrator's decision relating to breach of contract and the award of damages and are exploring the Company's legal options to attempt to set aside this decision and damages award.

The Company cannot provide any assurance on the likelihood of success in being able to challenge this decision or set aside the damages award. If the Company is unsuccessful in doing so, its financial condition will be adversely affected as the quantum of damages awarded to the Claimant exceed its existing cash reserves.

The Company will provide updates on this matter when it becomes aware of new material information.

Forward-Looking Statements:

This release contains forward-looking statements. Forward-looking statements, without limitation, may contain the words believes, expects, anticipates, estimates, intends, plans, or similar expressions. Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions and actual results could differ materially from those anticipated. Forward looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. In the context of any forward-looking information please refer to risk factors detailed in, as well as other information contained in the Company's filings with Canadian securities regulators (www.sedar.com).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Nexia Health Technologies Inc.


These press releases may also interest you

at 04:04
NaturVet, the 30-year pioneer and present-day innovator of the pet health and wellness industry, announces the latest innovation in the pet supplement realm: Breed Specific Soft Chews®. This new comprehensive line is made up of five products that...

at 04:01
Bizrahmed, a leading cosmetic center in Dubai, is delighted to announce the joining of internationally acclaimed British plastic surgeon, Mr. Norman Waterhouse. This strategic collaboration is set to be significant, as it boots the range of cosmetic...

at 04:00
Slone Partners, a nationwide executive search firm for life sciences, healthcare, and nonprofit and social impact organizations, has announced the placement of Chris A. Raanes as Chief Executive Officer (CEO) at Magnetic Insight, the global leader in...

at 03:05
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase 2a clinical trial with MH002 in the orphan disease...

at 03:00
Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that it has extended the menu of DxI 9000 Immunoassay...

at 03:00
Viewpoint, the esteemed educational program hosted by distinguished actor Dennis Quaid, is pleased to announce a collaborative effort with Medical Aid International for an upcoming episode dedicated to transforming healthcare in Low and Middle Income...



News published on and distributed by: